Glial fibrillary acidic protein: a promising biomarker in pediatric brain injury.

[1]  C. Thompson,et al.  Glial fibrillary acidic protein as a brain injury biomarker in children undergoing extracorporeal membrane oxygenation* , 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[2]  D. Creery,et al.  Severe traumatic brain injury in children elevates glial fibrillary acidic protein in cerebrospinal fluid and serum* , 2011, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[3]  A. Gabrielli,et al.  alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury. , 2009, Journal of neurotrauma.

[4]  A. Raabe,et al.  GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome. , 2004, Journal of neurotrauma.

[5]  A. Raabe,et al.  Glial fibrillary acidic protein in serum after traumatic brain injury and multiple trauma. , 2004, The Journal of trauma.

[6]  R. Berman,et al.  Early loss of astrocytes after experimental traumatic brain injury , 2003, Glia.

[7]  David J. Brenner,et al.  Estimating cancer risks from pediatric CT: going from the qualitative to the quantitative , 2002, Pediatric Radiology.

[8]  K. Haglid,et al.  Determination of S‐100 and Glial Fibrillary Acidic Protein Concentrations in Cerebrospinal Fluid After Brain Infarction , 1991, Stroke.